← Back to PRCT filing summaryOriginal filing text · Part I
Item 3 — Quantitative and Qualitative Disclosures About Market Risk
Procept Biorobotics Corporation · 10-Q · Q2 FY2026 · Period ended Jun 30, 2026
View complete filing on SEC EDGAR ↗This is the extracted source text from the SEC filing. Formatting may differ from the original document.
Our market risks related to interest rate, credit, foreign currency exchange rates, and effects of inflation are described in Part II, Item 7A, “Quantitative and Qualitative Disclosures About Market Risk”, of our 2025 Annual Report on Form 10-K. Our exposure to market risks has not changed materially since December 31, 2025.